Organization
Forest Hills Lab
2 clinical trials
1 abstract
Clinical trial
A Phase 2, Double-Blind, Multi-Center, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of FHL-301 in Adult Patients With Parkinson's DiseaseStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Phase 1, Randomized, Double-Blind, Single-Dose Escalation Study Followed by a Multiple-Dose Escalating Study of Glyceryl Tribenzoate (GTB) Capsules in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-10-19
Abstract
The impact of next generation sequencing on the management of urothelial cell carcinoma.Org: Long Island Jewish Forest Hills, Forest Hills Lab, Long Island Jewish Medical Center, Queens, NY, Northwell Health, New Hyde Park, NY,